RadNet (RDNT) Scheduled to Post Quarterly Earnings on Wednesday

RadNet (NASDAQ:RDNT - Get Free Report) will be posting its quarterly earnings results after the market closes on Wednesday, May 8th. Analysts expect RadNet to post earnings of ($0.09) per share for the quarter. Individual that wish to register for the company's earnings conference call can do so using this link.

RadNet (NASDAQ:RDNT - Get Free Report) last issued its earnings results on Friday, March 1st. The medical research company reported $0.20 EPS for the quarter, topping analysts' consensus estimates of $0.11 by $0.09. The firm had revenue of $420.38 million for the quarter, compared to the consensus estimate of $410.11 million. RadNet had a return on equity of 4.72% and a net margin of 0.19%. The company's revenue was up 9.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.11 earnings per share. On average, analysts expect RadNet to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

RadNet Price Performance

RDNT stock traded up $1.95 during mid-day trading on Wednesday, reaching $50.45. 1,019,270 shares of the company's stock were exchanged, compared to its average volume of 518,679. The company has a market cap of $3.73 billion, a price-to-earnings ratio of -2,423.79 and a beta of 1.69. The stock's 50 day moving average is $46.26 and its 200 day moving average is $38.33. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.32 and a quick ratio of 1.32. RadNet has a 12-month low of $25.11 and a 12-month high of $50.57.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on RDNT. StockNews.com downgraded RadNet from a "hold" rating to a "sell" rating in a research report on Thursday, April 11th. Truist Financial restated a "buy" rating and issued a $55.00 target price (up previously from $51.00) on shares of RadNet in a research report on Thursday, March 28th. Jefferies Financial Group raised their target price on RadNet from $47.00 to $58.00 and gave the company a "buy" rating in a research report on Friday, March 22nd. Finally, Barclays started coverage on RadNet in a research report on Wednesday, March 6th. They issued an "equal weight" rating and a $48.00 target price on the stock.

RadNet Company Profile

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.